CAROL EKE: Open Payments
NPI 1023598885 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 10 payments from 8 companies in 2025. Trend: 2023 $915 · 2024 $1,137 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 2 | $244 |
| Gilead Sciences, Inc. | 2 | $200 |
| Phathom Pharmaceuticals, Inc. | 1 | $131 |
| Verona Pharma, Inc. | 1 | $125 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $96 |
| PFIZER INC. | 1 | $93 |
| CMP Pharma, Inc. | 1 | $24 |
Products named: Epclusa, VOQUEZNA, Ohtuvayre, APRETUDE, SHINGRIX, JOURNAVX, PREVNAR 20, Atorvaliq.
Industry payments across TX — which companies pay providers there.
